Your account is not claimed yet. You can sign up with ORCID to claim your account.

Caleb Cornaby

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Venues

PloS one

ImmunoHorizons

Science immunology

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

University of North Carolina Hospitals

Brigham Young University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of North Carolina Hospitals Jul 1o 2019

United States

Clinical Immunology Fellow :: Pathology and Laboratory Medicine

Education History

Brigham Young University - Dec 12o 2017

United States

PHD :: Mircobiology and Molecular Biology

Publications

Caleb Cornaby, Eric T Weimer
Utilizing principal component analysis in the identification of clinically relevant changes in patient HLA single antigen bead solid phase testing patterns. PloS one 18 (10) (2023)
Erin C Steinbach, Johanna M Smeekens, Satyaki Roy, Takahiko Toyonaga, Caleb Cornaby, Layna B Perini, Ana E Berglind, Michael D Kulis, Edwin H Kim, Martin T Ferris, Terrence S Furey, Arvil Wesley Burks, Shehzad Z Sheikh
Intestinal epithelial cell barrier dysfunction and elevated Angiopoietin-like 4 identified in orally susceptible peanut allergy model. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2022)
Caleb Cornaby, Ahmed S Elshikha, Xiangyu Teng, Seung-Chul Choi, Yogesh Scindia, Anne Davidson, Laurence Morel
Efficacy of the Combination of Metformin and CTLA4Ig in the (NZB × NZW)F1 Mouse Model of Lupus Nephritis. ImmunoHorizons 4 (6) (2020)
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R Martinez, Rajendra Raut, Alena Janda Markmann, Caleb Cornaby, Luther Bartelt, Susan Weiss, Yara Park, Caitlin E Edwards, Eric T Weimer, Erin M Scherer, Nadine Rouphael, Srilatha Edupuganti, Daniela Weiskopf, Longping V Tse, Yixuan J Hou, David M Margolis, Alessandro Sette, Matthew H Collins, John L Schmitz, Ralph S Baric, Arivianda M DeSilva
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Science immunology 5 (48) (2020)

Caleb Cornaby.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Caleb Cornaby